Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients

Autor:	Alexandra Pedraza, Pedro Marín, Montserrat Rovira, Gonzalo Gutiérrez-García, Joan Cid, Ana Sofía Almeida Jorge, Luis Gerardo Rodríguez-Lobato, Laura Rosiñol, Alvaro Urbano-Ispizua, Cristina Gallego, Carmen Martinez, Pedro Puerta-Alcalde, Francesc Fernández-Avilés, Carolina Garcia-Vidal, María Suárez-Lledó, Adelina Hernando, Alexandra Martínez-Roca, Susana Segura, Celia Cardozo, David Moreno, Miquel Lozano
Rok vydání:	2020
Předmět:	Cancer Research medicine.medical_specialty Lymphoma Transplantation Autologous 03 medical and health sciences 0302 clinical medicine Autologous stem-cell transplantation Ambulatory care Internal medicine Medicine Humans Antibiotic prophylaxis Hospital readmission business.industry Neutropenic fever Hematopoietic Stem Cell Transplantation Hematology Antibiotic Prophylaxis medicine.disease Anti-Bacterial Agents Transplantation Oncology 030220 oncology & carcinogenesis business 030215 immunology
Zdroj:	Leukemialymphoma. 61(7)
ISSN:	1029-2403
Popis:	Despite the use of fluoroquinolone (FQ) prophylaxis, neutropenic fever (NF) is the most frequent cause of hospital readmission in ambulatory care programs for patients treated with autologous stem cell transplantation (ASCT). We analyzed the impact of intensifying primary prophylaxis with the addition of piperacillin/tazobactam (PT) to FQ. Between January 2002 and August 2018, 154 lymphoma patients conditioned with BEAM were included (40% received ceftriaxone (Ct) plus FQ and 60% PT plus FQ). NF and hospital readmission were required in 84 vs. 41% (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb9d279d7f32416b4bf880a9b9a717b2 https://pubmed.ncbi.nlm.nih.gov/32208787 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.